Journal of Shandong University (Health Sciences) ›› 2021, Vol. 59 ›› Issue (9): 97-102.doi: 10.6040/j.issn.1671-7554.0.2021.0826
Previous Articles Next Articles
SHI Yuhua, WANG Qiumin, QI Dan
CLC Number:
[1] Vander Borght M, Wyns C. Fertility and infertility: Definition and epidemiology[J]. Clin Biochem, 2018, 62: 2-10. doi:10.1016/j.clinbiochem.2018.03.012. [2] 刘淑文, 张淑霞, 刘玉双, 等. 不孕症的病因病机分析[J]. 实用妇科内分泌电子杂志, 2019, 6(12): 70. [3] De Geyter C. Assisted reproductive technology: impact on society and need for surveillance[J]. Best Pract Res Clin Endocrinol Metab, 2019, 33(1): 3-8. [4] 张燕, 言懿. 辅助生殖第一大国[J]. 中国经济周刊, 2021(11): 32-35. [5] Esteves SC, Humaidan P, Roque M, et al. Female infertility and assisted reproductive technology[J]. Panminerva Med, 2019, 61(1): 1-2. [6] 黄国宁. 2019年辅助生殖技术学科新进展[J]. 中华医学信息导报, 2020, 35(2): 17. [7] Brezina PR, Brezina DS, Kearns WG. Preimplantation genetic testing[J]. BMJ, 2012, 345: e5908. doi:10.1136/bmj.e5908. [8] Kuliev A, Rechitsky S. Preimplantation genetic testing: current challenges and future prospects[J]. Expert Rev Mol Diagn, 2017, 17(12): 1071-1088. [9] Greco E, Litwicka K, Minasi MG, et al. Preimplantation genetic tsting: where we are today[J]. Int J Mol Sci, 2020, 21(12): 4381. [10] 应瑛, 刘见桥. 以辅助生殖技术为基础的临床新技术的发展[J]. 实用妇产科杂志, 2020, 36(4): 251-253. [11] Takeuchi K. Pre-implantation genetic testing: past, present, future[J]. Reprod Med Biol, 2021, 20(1): 27-40. [12] Chen ZJ, Shi YH, Sun Y, et al. Fresh versus frozen embryos for infertility in the polycystic ovary syndrome[J]. N Engl J Med, 2016, 375(6): 523-533. [13] Shi YH, Sun Y, Hao CF, et al. Transfer of fresh versus frozen embryos in ovulatory women[J]. N Engl J Med, 2018, 378(2): 126-136. [14] Magli MC, Pomante A, Cafueri G, et al. Preimplantation genetic testing: polar bodies, blastomeres, trophectoderm cells, or blastocoelic fluid?[J]. Fertil Steril, 2016, 105(3): 676-683. [15] Zhang Y, Li N, Wang L, et al. Molecular analysis of DNA in blastocoele fluid using next-generation sequencing[J]. J Assist Reprod Genet, 2016, 33(5): 637-645. [16] Capalbo A, Romanelli V, Patassini C, et al. Diagnostic efficacy of blastocoel fluid and spent media as sources of DNA for preimplantation genetic testing in standard clinical conditions[J]. Fertil Steril, 2018, 110(5): 870-879. [17] Ho JR, Arrach N, Rhodes-Long K, et al. Pushing the limits of detection: investigation of cell-free DNA for aneuploidy screening in embryos[J]. Fertil Steril, 2018, 110(3): 467-475. [18] Sharma H, Singh D, Mahant A, et al. Development of mitochondrial replacement therapy: a review[J]. Heliyon, 2020, 6(9): e04643. [19] Babayev E, Seli E. Oocyte mitochondrial function and reproduction[J]. Curr Opin Obstet Gynecol, 2015, 27(3): 175-181. [20] Zou W, Slone J, Cao Y, et al. Mitochondria and their role in human reproduction[J]. DNA Cell Biol, 2020, 39(8): 1370-1378. [21] Wolf DP, Mitalipov N, Mitalipov S. Mitochondrial replacement therapy in reproductive medicine[J]. Trends Mol Med, 2015, 21(2): 68-76. [22] Wu K, Chen T, Huang S, et al. Mitochondrial replacement by pre-pronuclear transfer in human embryos[J]. Cell Res, 2017, 27(6): 834-837. [23] Wu K, Zhong C, Chen T, et al. Polar bodies are efficient donors for reconstruction of human embryos for potential mitochondrial replacement therapy[J]. Cell Res, 2017, 27(8): 1069-1072. [24] 张迪, 刘欢. 线粒体置换技术的伦理学反思[J]. 中国医学伦理学, 2018, 31(7): 873-878. ZHANG Di, LIU Huan. Ethical reflection on the technique of mitochondria replacement[J]. Chinese Medical Ethics, 2018, 31(7): 873-878. [25] Sciorio R, Thong KJ, Pickering SJ. Single blastocyst transfer(SET)and pregnancy outcome of day 5 and day 6 human blastocysts vitrified using a closed device[J]. Cryobiology, 2018, 84: 40-45. doi:10.1016/j.cryobiol.2018.08.004. [26] Sciorio R, Thong KJ, Pickering SJ. Increased pregnancy outcome after day 5 versus day 6 transfers of human vitrified-warmed blastocysts[J]. Zygote, 2019, 27(5): 279-284. [27] Johnston J, Gusmano MK, Patrizio P. Preterm births, multiples, and fertility treatment: recommendations for changes to policy and clinical practices[J]. Fertil Steril, 2014, 102(1): 36-39. [28] Roque M, Haahr T, Geber S, et al. Fresh versus elective frozen embryo transfer in IVF/ICSI cycles: a systematic review and meta-analysis of reproductive outcomes[J]. Hum Reprod Update, 2019, 25(1): 2-14. [29] Practice Committee of Society for Assisted Reproductive Technology, Practice Committee of American Society for Reproductive Medicine.Elective single-embryo transfer[J]. Fertil Steril, 2012, 97(4): 835-842. [30] Wei D, Liu JY, Sun Y, et al. Frozen versus fresh single blastocyst transfer in ovulatory women: a multicentre, randomised controlled trial[J]. Lancet, 2019, 393(10178): 1310-1318. [31] Liu F, Jiang Q, Sun X, et al. Lipid metabolic disorders and ovarian hyperstimulation syndrome: a retrospective analysis[J]. Front Physiol, 2020, 11: 491892. doi:10.3389/fphys.2020.491892. [32] Maheshwari A, Pandey S, Amalraj Raja E, et al. Is frozen embryo transfer better for mothers and babies? Can cumulative meta-analysis provide a definitive answer?[J]. Hum Reprod Update, 2018, 24(1): 35-58. [33] Zhang B, Wei D, Legro RS, et al. Obstetric complications after frozen versus fresh embryo transfer in women with polycystic ovary syndrome: results from a randomized trial[J]. Fertil Steril, 2018, 109(2): 324-329. [34] Pan Y, Li B, Wang Z, et al. Hormone replacement versus natural cycle protocols of endometrial preparation for frozen embryo transfer[J]. Front Endocrinol, 2020, 11: 546532. doi:10.3389/fendo.2020.546532. [35] Lin J, Zhao JZ, Hao GM, et al. Maternal and neonatal complications after natural vs. hormone replacement therapy cycle regimen for frozen single blastocyst transfer[J]. Front Med, 2020, 7: 338. doi:10.3389/fmed.2020.00338. [36] Wang Z, Liu H, Song H, et al. Increased risk of pre-eclampsia after frozen-thawed embryo transfer in programming cycles[J]. Front Med(Lausanne), 2020, 7: 104. doi:10.3389/fmed.2020.00104. [37] Pourakbari R, Ahmadi H, Yousefi M, et al. Cell therapy in female infertility-related diseases: Emphasis on recurrent miscarriage and repeated implantation failure[J]. Life Sci, 2020, 258: 118181. doi:10.1016/j.lfs.2020.118181. [38] Yu N, Zhang B, Xu M, et al. Intrauterine administration of autologous peripheral blood mononuclear cells(PBMCs)activated by HCG improves the implantation and pregnancy rates in patients with repeated implantation failure: a prospective randomized study[J]. Am J Reprod Immunol, 2016, 76(3): 212-216. [39] Yoshioka S, Fujiwara H, Nakayama T, et al. Intrauterine administration of autologous peripheral blood mononuclear cells promotes implantation rates in patients with repeated failure of IVF-embryo transfer[J]. Hum Reprod, 2006, 21(12): 3290-3294. [40] Li S, Wang J, Cheng Y, et al. Intrauterine administration of hCG-activated autologous human peripheral blood mononuclear cells(PBMC)promotes live birth rates in frozen/thawed embryo transfer cycles of patients with repeated implantation failure[J]. J Reprod Immunol, 2017, 119: 15-22. doi:10.1016/j.jri.2016.11.006. [41] Chen J, Liu B, Zhang Y, et al. Effect of immunotherapy on patients with unexplained recurrent spontaneous abortion[J]. Ann Palliat Med, 2020, 9(5): 2545-2550. [42] Gharesi-Fard B, Zolghadri J, Kamali-Sarvestani E. Effect of leukocyte therapy on tumor necrosis factor-alpha and interferon-gamma production in patients with recurrent spontaneous abortion[J]. Am J Reprod Immunol, 2008, 59(3): 242-250. [43] Lee SK, Kim JY, Hur SE, et al. An imbalance in interleukin-17-producing T and Foxp3+ regulatory T cells in women with idiopathic recurrent pregnancy loss[J]. Hum Reprod, 2011, 26(11): 2964-2971. [44] Raghupathy R, Makhseed M, Azizieh F, et al. Cytokine production by maternal lymphocytes during normal human pregnancy and in unexplained recurrent spontaneous abortion[J]. Hum Reprod, 2000, 15(3): 713-718. [45] Fotouhi A, Maleki A, Dolati S, et al. Platelet rich plasma, stromal vascular fraction and autologous conditioned serum in treatment of knee osteoarthritis[J]. 2018, 104: 652-660. doi:10.1093/humrep/15.3.713. [46] Amable PR, Carias RB, Teixeira MV, et al. Platelet-rich plasma preparation for regenerative medicine: optimization and quantification of cytokines and growth factors[J]. Stem Cell Res Ther, 2013, 4(3): 67. [47] Sato Y, Fujiwara H, Zeng BX, et al. Platelet-derived soluble factors induce human extravillous trophoblast migration and differentiation: platelets are a possible regulator of trophoblast infiltration into maternal spiral arteries[J]. Blood, 2005, 106(2): 428-435. [48] Fujiwara H. Immune cells contribute to systemic cross-talk between the embryo and mother during early pregnancy in cooperation with the endocrine system[J]. Reprod Med Biol, 2006, 5(1): 19-29. [49] Chang Y, Li J, Chen Y, et al. Autologous platelet-rich plasma promotes endometrial growth and improves pregnancy outcome during in vitro fertilization[J]. Int J Clin Exp Med, 2015, 8(1): 1286-1290. [50] Tandulwadkar SR, Naralkar MV, Surana AD, et al. Autologous intrauterine platelet-rich plasma instillation for suboptimal endometrium in frozen embryo transfer cycles: a pilot study[J]. J Hum Reprod Sci, 2017, 10(3): 208-212. [51] Ullah I, Subbarao RB, Rho GJ. Human mesenchymal stem cells-current trends and future prospective[J]. Biosci Rep, 2015, 35(2): e00191. [52] Spitzhorn LS, Megges M, Wruck W, et al. Human iPSC-derived MSCs(iMSCs)from aged individuals acquire a rejuvenation signature[J]. Stem Cell Res Ther, 2019, 10(1): 100. [53] Rungsiwiwut R, Virutamasen P, Pruksananonda K. Mesenchymal stem cells for restoring endometrial function: an infertility perspective[J]. Reprod Med Biol, 2021, 20(1): 13-19. [54] Ling L, Feng X, Wei T, et al. Human amnion-derived mesenchymal stem cell(hAD-MSC)transplantation improves ovarian function in rats with premature ovarian insufficiency(POI)at least partly through a paracrine mechanism[J]. Stem Cell Res Ther, 2019, 10(1): 46. [55] Yoon SY. Mesenchymal stem cells for restoration of ovarian function[J]. Clin Exp Reprod Med, 2019, 46(1): 1-7. [56] Zhao YX, Chen SR, Su PP, et al. Using mesenchymal stem cells to treat female infertility: an update on female reproductive diseases[J]. Stem Cells Int, 2019, 2019: 9071720. doi:10.1155/2019/9071720. |
[1] | Guimin HAO,Zhuoye LUO,Yizhuo WANG. Ethical issues and considerations in fertility preservation [J]. Journal of Shandong University (Health Sciences), 2022, 60(9): 47-52. |
[2] | Yuhua SHI,Ye PAN,Yanqiu XIE. Latest advances of embryo cryopreservation technology [J]. Journal of Shandong University (Health Sciences), 2022, 60(9): 12-18. |
[3] | Lei YAN,Caixin YUE,Yichun LIU. Fertility preservation in patients with endometriosis [J]. Journal of Shandong University (Health Sciences), 2022, 60(9): 31-34. |
[4] | ZHAO Bingqing, GAO Xuan, LI Jiangxia. A retrospective analysis of chromosome karyotypes in RSA couples from assisted reproductive population [J]. Journal of Shandong University (Health Sciences), 2021, 59(7): 26-31. |
[5] | ZHU Xuli, ZHOU Liang, WANG Yue, SUN Qingyun, CAO Mingya, DU Yuanjie, CAO Jinfeng, ZHAO Zhiming, HAO Guimin. Correlation analysis of freezing methods with different sperm sources and pregnancy outcomes [J]. Journal of Shandong University (Health Sciences), 2021, 59(6): 86-93. |
[6] | CAO Mingya, ZHAO Hanjie, FENG Tengfei, JIA Rui, ZHAO Zhiming, HAO Guimin. Effect of fetal reduction in early pregnancy on perinatal mothers and infants after embryo transfer [J]. Journal of Shandong University (Health Sciences), 2020, 58(11): 65-70. |
[7] | WU Depei, CHEN Xiaochen. Current situation and prospect of immunotherapy for lymphoma [J]. Journal of Shandong University (Health Sciences), 2019, 57(7): 13-20. |
[8] | LIU Zilin, LI Dong, SHI Qing, LI Cong, HUANG Jinxian, ZHU Huasu, JU Xiuli. Therapy of rat denervated gastrocnemius muscles damage using human cord blood mononuclear cells [J]. Journal of Shandong University (Health Sciences), 2019, 57(2): 61-69. |
[9] | TAN Jichun, DONG Meng, LI Pingping. Common ethical issues on assisted reproductive technology and their management [J]. Journal of Shandong University (Health Sciences), 2019, 57(10): 60-66. |
[10] | HUANG Wei, ZHU Huili. Prevention and treatment of ectopic pregnancy after assisted reproductive technology [J]. Journal of Shandong University (Health Sciences), 2019, 57(10): 27-32. |
[11] | ZHANG Yingchun. Safety of human assisted reproductive technology offspring [J]. Journal of Shandong University (Health Sciences), 2019, 57(10): 52-59. |
[12] | WU Qiongfang. Possible causes and treatment of postoperative bleeding after transvaginal oocyte retrieval in assisted reproductive therapy [J]. Journal of Shandong University (Health Sciences), 2019, 57(10): 33-37. |
[13] | ZHAO Junli, YUAN Yingying. Prevention and treatment of multiple pregnancy in assisted reproductive therapy [J]. Journal of Shandong University (Health Sciences), 2019, 57(10): 20-26. |
[14] | SHI Yuhua, JIANG Qi. Prevention and treatment of ovarian hyperstimulation syndrome in assisted reproductive therapy [J]. Journal of Shandong University (Health Sciences), 2019, 57(10): 13-19. |
[15] | HAO Guimin, LUO Zhuoye, CUI Na. Hazards of common complications in assisted reproductive technology [J]. Journal of Shandong University (Health Sciences), 2019, 57(10): 7-12. |
|